Page last updated: 2024-10-31

mitotane and Pseudohypoparathyroidism

mitotane has been researched along with Pseudohypoparathyroidism in 1 studies

Mitotane: A derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression.

Pseudohypoparathyroidism: A hereditary syndrome clinically similar to HYPOPARATHYROIDISM. It is characterized by HYPOCALCEMIA; HYPERPHOSPHATEMIA; and associated skeletal development impairment and caused by failure of response to PARATHYROID HORMONE rather than deficiencies. A severe form with resistance to multiple hormones is referred to as Type 1a and is associated with maternal mutant allele of the ALPHA CHAIN OF STIMULATORY G PROTEIN.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Courvoisier, B1

Other Studies

1 other study available for mitotane and Pseudohypoparathyroidism

ArticleYear
[Clinical reports: pseudohypoparathyroidism, pituitary nanism, and adrenal carcinoma].
    Schweizerische medizinische Wochenschrift. Supplementum, 1982, Volume: 13

    Topics: 17-Hydroxycorticosteroids; Acne Vulgaris; Adrenal Gland Neoplasms; Adult; Androgens; Dihydrotachyste

1982